BioTek Among 5x5x5 Growth Award Special Honorees
News Sep 21, 2012
For the third time in five years, BioTek Instruments was recognized as a recipient of the 5x5x5 Growth Award at the 10th annual awards ceremony on Monday, September 17, 2012.
This annual award is sponsored by Vermont Business Magazine and KeyBank, and is presented to Vermont companies experiencing outstanding growth in one of five business categories.
BioTek was recognized in this year’s “10x10” category, marking Vermont’s Top 10 companies in terms of sales growth over 10 years, and also honoring the award’s 10th anniversary. BioTek also received the 5x5x5 award in 2008 and 2011.
“I’m honored to receive this award on behalf of BioTek, and to celebrate our growth in the great state of Vermont,” noted Briar Alpert, BioTek’s President and CEO.
Alpert continued, “And above all else, I’m proud of the BioTekkers that work as a team every day to reach our goals, and to make BioTek one of the best companies in Vermont.”
"On the 10th anniversary of the 5x5x5 Awards we decided to honor, for the first time, the fastest growing Vermont companies over the past ten years and it was no surprise that our data pointed right to BioTek Instruments as one of these great companies”, commented John Boutin, Publisher of Vermont Business Magazine.
Boutin continued, “With their commitment to their employees, the environment and their community, it proves you can do all that and still have a very successful company right here in the state of Vermont."
PhoreMost and o2h Discovery Collaborate to Progress First-in-Class Drug Discovery ProgramsNews
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, announced it has entered into a collaboration with o2h discovery (o2h), an Anglo-Indian medicinal chemistry company that has in-house capability to take drug discovery programmes to the IND filing stage.READ MORE
Simple Sugar Prevents Neurodegeneration in Lysosomal Storage DiseaseNews
New therapeutic approach may one day delay neurodegeneration typical of a disease called mucopolysaccharidoses IIIB (MPS IIIB)READ MORE
Penn Medicine Biochemist Receives Major Award for Research on Epigenetic Protein Modifications via Mass SpecNews
Benjamin A.Garcia, PhD, an expert in quantitative proteomics and Presidential Professor of Biochemistry and Biophysics in the Perelman School of Medicine at the University of Pennsylvania, has been awarded the Biemann Medal by the American Society for Mass Spectrometry (ASMS). The early-career award recognizes significant achievement in basic or applied mass spectrometry.